Literature DB >> 10752531

Vascular proliferation and enhanced expression of endothelial nitric oxide synthase in human peritoneum exposed to long-term peritoneal dialysis.

Sophie Combet1,2, Toshio Miyata3, Pierre Moulin4, Dominique Pouthier5, Eric Goffin1, Olivier Devuyst1.   

Abstract

Long-term peritoneal dialysis (PD) is associated with alterations in peritoneal permeability and loss of ultrafiltration. These changes originate from increased peritoneal surface area, but the morphologic and molecular mechanisms involved remain unknown. The hypothesis that modifications of activity and/or expression of nitric oxide synthase (NOS) isozymes might play a role in these modifications, via enhanced local production of nitric oxide, was tested in this study. NOS activities were measured by the L-citrulline assay in peritoneal biopsies from seven control subjects, eight uremic patients immediately before the onset of PD, and 13 uremic patients on short-term (<18 mo, n = 6) or long-term(>18 mo, n = 7) PD. Peritoneal NOS activity is increased fivefold in long-term PD patients compared with control subjects. In uremic patients, NOS activity is positively correlated with the duration of PD. Increased NOS activity is mediated solely by Ca(2+)-dependent NOS and, as shown by immunoblotting, an upregulation of endothelial NOS. The biologic relevance of increased NOS in long-term PD was demonstrated by enhanced nitrotyrosine immunoreactivity and a significant increase in vascular density and endothelial area in the peritoneum. Immunoblotting and immunostaining studies demonstrated an upregulation of vascular endothelial growth factor (VEGF) mostly along the endothelium lining peritoneal blood vessels in long-term PD patients. In the latter, VEGF colocalized with the advanced glycation end product pentosidine deposits. These data provide a morphologic (angiogenesis and increased endothelial area) and molecular (enhanced NOS activity and endothelial NOS upregulation) basis for explaining the permeability changes observed in long-term PD. They also support the implication of local advanced glycation end product deposits and liberation of VEGF in that process.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10752531     DOI: 10.1681/ASN.V114717

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  37 in total

1.  Fluid dwell impact induces peritoneal fibrosis in the peritoneal cavity reconstructed in vitro.

Authors:  Shigehisa Aoki; Mitsuru Noguchi; Toshiaki Takezawa; Satoshi Ikeda; Kazuyoshi Uchihashi; Hiroyuki Kuroyama; Tomoyuki Chimuro; Shuji Toda
Journal:  J Artif Organs       Date:  2015-08-30       Impact factor: 1.731

2.  Immunolocalization of caveolin-1 in rat and human mesothelium.

Authors:  Christopher J von Ruhland; Lee Campbell; Mark Gumbleton; Bharat Jasani; Geoffrey R Newman
Journal:  J Histochem Cytochem       Date:  2004-11       Impact factor: 2.479

3.  Pharmacological inhibition of heparin-binding EGF-like growth factor promotes peritoneal angiogenesis in a peritoneal dialysis rat model.

Authors:  Zhenyuan Li; Hao Yan; Jiangzi Yuan; Liou Cao; Aiwu Lin; Huili Dai; Zhaohui Ni; Jiaqi Qian; Wei Fang
Journal:  Clin Exp Nephrol       Date:  2017-07-14       Impact factor: 2.801

Review 4.  Peritoneal damage by peritoneal dialysis solutions.

Authors:  Takafumi Ito; Noriaki Yorioka
Journal:  Clin Exp Nephrol       Date:  2008-02-15       Impact factor: 2.801

5.  Restoration of peritoneal integrity after withdrawal of peritoneal dialysis: characteristic features of the patients at risk of encapsulating peritoneal sclerosis.

Authors:  Yasushi Otsuka; Masaaki Nakayama; Masato Ikeda; Ali M Sherif; Keitaro Yokoyama; Hiroyasu Yamamoto; Yoshindo Kawaguchi
Journal:  Clin Exp Nephrol       Date:  2005-12       Impact factor: 2.801

6.  The promising future of long-term peritoneal dialysis.

Authors:  Dimitrios Oreopoulos; Elias Thodis; Kosmas I Paraskevas
Journal:  Int Urol Nephrol       Date:  2008       Impact factor: 2.370

Review 7.  Effect of Neutral-pH, Low-Glucose Degradation Product Peritoneal Dialysis Solutions on Residual Renal Function, Urine Volume, and Ultrafiltration: A Systematic Review and Meta-Analysis.

Authors:  Seychelle Yohanna; Ali M A Alkatheeri; Scott K Brimble; Brendan McCormick; Arthur Iansavitchous; Peter G Blake; Arsh K Jain
Journal:  Clin J Am Soc Nephrol       Date:  2015-06-05       Impact factor: 8.237

8.  Interstitial Fibrosis Restricts Osmotic Water Transport in Encapsulating Peritoneal Sclerosis.

Authors:  Johann Morelle; Amadou Sow; Nicolas Hautem; Caroline Bouzin; Ralph Crott; Olivier Devuyst; Eric Goffin
Journal:  J Am Soc Nephrol       Date:  2015-01-30       Impact factor: 10.121

Review 9.  Can peritoneal dialysis be used as a long term therapy for end stage renal disease?

Authors:  Michele Giannattasio; Michele Buemi; Flavia Caputo; Giusto Viglino; Enrico Verrina
Journal:  Int Urol Nephrol       Date:  2003       Impact factor: 2.370

10.  Nitric oxide synthase isoforms play distinct roles during acute peritonitis.

Authors:  Jie Ni; Rachel M McLoughlin; Alexandre Brodovitch; Pierre Moulin; Peter Brouckaert; Barbara Casadei; Olivier Feron; Nicholas Topley; Jean-Luc Balligand; Olivier Devuyst
Journal:  Nephrol Dial Transplant       Date:  2009-08-25       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.